Jay Curwin, MD
Clinical Cardiac Electrophysiology · Morristown, NJNPI 1396775391
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Medtronic at 26.5% of the total. Reporting peaked in 2024 at $1,091 and has fallen 60.9% since, to $427 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NJ, where the typical reported total is $15,131.
Across 144 payments — averaging $32.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Boston Scientific$810
- Abbott$674
- Irhythm Technologies, Inc.$442
- Biosense Webster, Inc.$381
- Kestra Medical Technology Services, Inc.$223
- plus $882 from 14 others
Across 9 payments — averaging $2715.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$24K
What the payments were for
- Food & beverage$4,60099%
- Education$441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 30 | $1,232 |
| Boston Scientific | 24 | $810 |
| Abbott | 14 | $674 |
| Irhythm Technologies, Inc. | 17 | $442 |
| Biosense Webster, Inc. | 4 | $381 |
| Kestra Medical Technology Services, Inc. | 9 | $223 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $217 |
| Pfizer | 7 | $111 |
| Baxter Healthcare | 2 | $92 |
| Sanofi-aventis U.S. LLC | 5 | $90 |
| Johnson & Johnson | 6 | $89 |
| E.r. Squibb & Sons, L.L.C. | 4 | $66 |
| Biotronik Inc. | 1 | $44 |
| Amgen | 3 | $44 |
| Portola Pharmaceuticals, LLC | 2 | $30 |
| Philips North America LLC | 1 | $28 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| Cordis US CORP. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Bardy Diagnostics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFFERA MAPPING SYSTEM$171
- SelectSecure$142
- JOT DX$141
- QDOT MICRO Catheter$140
- WATCHMAN FLX$138
- OCTARAY MAPPING CATHETER$122
- Reveal LINQ$121
- Fortify Assura, Ellipse ICD$114
- Micra$102
How this compares
$4,644 in reported general payments places this provider in the 15th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $41,149 |
| Dofetilide | 26 | $6,027 |
| Mexiletine Hcl | 13 | $1,517 |
| Flecainide Acetate | 42 | $1,477 |
| Amiodarone Hcl | 37 | $1,075 |
| Metoprolol Succinate | 49 | $671 |
| SotalolSotalol Hcl | 12 | $245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $111 | $41,14929 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Morristown
- Stephen WintersMorristown$52K
- Jonathan SussmanMorristown$41K
- Michael KatzMorristown$23K
- Timothy MahoneyMorristown$19K
- Robert CoyneMorristown$16K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.